Russell Investments Group’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$437K Buy
+82,378
New +$437K ﹤0.01% 2385
2024
Q4
Sell
-3,954
Closed -$108K 3763
2024
Q3
$108K Buy
3,954
+581
+17% +$15.9K ﹤0.01% 2643
2024
Q2
$82.5K Buy
3,373
+3,342
+10,781% +$81.7K ﹤0.01% 2666
2024
Q1
$661 Hold
31
﹤0.01% 3168
2023
Q4
$593 Buy
+31
New +$593 ﹤0.01% 3110
2023
Q3
Sell
-668
Closed -$15.5K 3587
2023
Q2
$15.5K Hold
668
﹤0.01% 2888
2023
Q1
$15.5K Sell
668
-41,162
-98% -$956K ﹤0.01% 2841
2022
Q4
$607K Hold
41,830
﹤0.01% 2205
2022
Q3
$797K Sell
41,830
-252
-0.6% -$4.8K ﹤0.01% 2034
2022
Q2
$763K Hold
42,082
﹤0.01% 2081
2022
Q1
$1.06M Sell
42,082
-26,380
-39% -$664K ﹤0.01% 1929
2021
Q4
$1.89M Buy
68,462
+22,044
+47% +$608K ﹤0.01% 1834
2021
Q3
$1.5M Sell
46,418
-17,745
-28% -$573K ﹤0.01% 1995
2021
Q2
$1.96M Sell
64,163
-57,100
-47% -$1.75M ﹤0.01% 1935
2021
Q1
$3.69M Sell
121,263
-29,952
-20% -$912K 0.01% 1523
2020
Q4
$2.99M Sell
151,215
-164,389
-52% -$3.25M 0.01% 1538
2020
Q3
$4.11M Buy
315,604
+102,206
+48% +$1.33M 0.01% 1249
2020
Q2
$2.41M Buy
213,398
+1,751
+0.8% +$19.8K 0.01% 1518
2020
Q1
$3.05M Sell
211,647
-62,684
-23% -$902K 0.01% 1239
2019
Q4
$7.34M Sell
274,331
-81,466
-23% -$2.18M 0.01% 999
2019
Q3
$10.2M Sell
355,797
-47,769
-12% -$1.36M 0.02% 846
2019
Q2
$10.9M Sell
403,566
-56,499
-12% -$1.52M 0.02% 836
2019
Q1
$15.9M Sell
460,065
-191,524
-29% -$6.61M 0.03% 668
2018
Q4
$18.7M Buy
651,589
+39,023
+6% +$1.12M 0.04% 533
2018
Q3
$28.3M Sell
612,566
-10,305
-2% -$477K 0.05% 415
2018
Q2
$23.2M Sell
622,871
-448,225
-42% -$16.7M 0.05% 472
2018
Q1
$31.7M Buy
1,071,096
+4,865
+0.5% +$144K 0.05% 399
2017
Q4
$36.9M Sell
1,066,231
-85,684
-7% -$2.96M 0.06% 370
2017
Q3
$41.7M Buy
1,151,915
+78,798
+7% +$2.85M 0.07% 341
2017
Q2
$27.7M Sell
1,073,117
-42,716
-4% -$1.1M 0.05% 470
2017
Q1
$21.4M Buy
1,115,833
+7,113
+0.6% +$137K 0.04% 546
2016
Q4
$18.6M Buy
+1,108,720
New +$18.6M 0.04% 578